दवाओं की अंतःक्रिया
Bromocriptine + Dihydroergotamine intranasal
गंभीरता: गंभीर
Bromocriptine and Dihydroergotamine intranasal: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Intranasal dihydroergotamine is absorbed systemically and combined with bromocriptine may add to ergot-related vasoconstriction, causing hypertension, vasospasm or peripheral ischemia. The combination offers little benefit relative to its risk.
इस इंटरैक्शन का सरल भाषा में अर्थ
Bromocriptine and Dihydroergotamine intranasal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
ऐसा क्यों होता है
Additive pharmacodynamic vasoconstrictive and ergot-related effects at vascular receptors.
क्या करें
Avoid the combination and use a non-ergot migraine therapy if bromocriptine is required. If both are used, monitor blood pressure and for signs of ischemia.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Bromocriptine और Dihydroergotamine intranasal की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 7 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Bromocriptine के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Bromocriptine with Dihydroergotamine intranasal?
MediHelp rates the interaction as major. Bromocriptine and Dihydroergotamine intranasal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Intranasal dihydroergotamine is absorbed systemically and combined with bromocriptine may add to ergot-related vasoconstriction, causing hypertension, vasospasm or peripheral ischemia. The combination offers little benefit relative to its risk.
How serious is the interaction between Bromocriptine and Dihydroergotamine intranasal?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use a non-ergot migraine therapy if bromocriptine is required. If both are used, monitor blood pressure and for signs of ischemia.
What other medicines interact with Bromocriptine?
MediHelp also lists interactions of Bromocriptine with, for example, Amisulpride, Atazanavir, Cobicistat. The full list is on the Bromocriptine page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
